INVICTA DIAGNOSTIC LTD Share Price

INVICTA DIAGNOSTIC LTD Share Price

NSE: INVICTA
|
Healthcare
₹ 67.00
+₹0.25 (0.37%)
1D
Last updated 31 Jul, 2026, 15:19 IST

INVICTA DIAGNOSTIC LTD Share Price Today

As of 1 Aug 2026, INVICTA DIAGNOSTIC LTD share price is ₹67.00. The stock opened at ₹66.00, compared to its previous close of ₹66.75. During today's trading session, INVICTA DIAGNOSTIC LTD share price moved in the range of ₹66.00 to ₹68.80, with an average price of ₹67.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹58.10 and a high of ₹105.00. On the performance front, INVICTA DIAGNOSTIC LTD share price has increased by 5.66% over the last six months and is down 29.52% on a year-on-year basis.

₹66.00
0.37% up today
₹68.80
1D LOW
1D HIGH

INVICTA DIAGNOSTIC LTD Returns Calculator

Circuit
L
H
₹54.55
₹81.75
52-week
L
H
₹58.10
₹105.00
Mkt Cap Cr
0.00
P/E
15.17
P/B
1.71
ROE
11.26%
D/E
0.00
ROCE
14.86%
Div. Yield
0.00%
EPS(TTM)
5.56
Turnover
0.41
EV/EBITDA
—
Net Margin
0.00%
Op. Margin
0.00%
ROA
—
Quick Ratio
0.00
Curr. Ratio
9.61
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Invicta Diagnos. has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Invicta Diagnos. appears to be fairly valued compared to its peers
Step 3 of 5
Earnings
Neutral
Invicta Diagnos. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,29,211.0064.5213.6420.48%0.3217.27%692.920.22%0.70103.81
Max Healthcare1,09,636.0064.898.7114.33%0.0813.72%10.470.21%0.287.37
Fortis Healthcare71,604.0057.586.0611.31%0.2213.36%6.500.13%0.163.05
Aster DM Healthcare71,638.40167.7215.648.48%0.3110.10%53.530.22%0.465.20
Narayana Hrudayalaya41,435.2040.737.2319.75%0.7514.52%12.630.28%0.8524.77
Global Health38,061.5068.699.6114.05%0.0615.26%149.240.04%0.7318.46
KRISHNA INST OF MED SCI L33,789.50140.169.0510.74%0.637.99%93.540.00%0.466.52
Dr. Lal Path Labs31,489.1057.6412.5520.13%0.0825.56%147.521.09%0.9130.45
Poly Medicure17,262.5052.795.4510.37%0.0812.71%301.180.21%0.5333.15
Syngene International16,100.3072.923.337.76%0.049.67%116.550.31%0.507.58

INVICTA DIAGNOSTIC LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Revenue₹30.10₹7.99
Other Income₹0.57₹0.35
Total Revenue₹30.66₹8.34
Total Expenses₹23.80₹5.65
Profit Before Tax₹6.86₹2.69
Tax₹2.17₹0.00
Profit After Tax₹4.69₹2.69
EPS - Basic₹5.57₹3.19
EPS - Diluted₹5.57₹3.19

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Profit before tax₹6.86₹2.69
Income before WC changes₹9.58₹4.34
Change in Assets-₹0.75-₹1.26
Change in Liabilities-₹1.26₹2.24
Change in WC-₹2.01₹0.98
Cash flow from Operations₹6.47₹4.21
Cash flow from Investing-₹5.23-₹10.01
Cash flow from Financing-₹0.42₹7.14
Total Cash Flow₹0.83₹1.34
Cash (Start of the year)₹1.34₹0.00
Cash (End of the year)₹2.16₹1.34

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Non-Current Assets₹14.87₹12.13
Current Assets₹6.38₹3.71
Total Assets₹21.25₹15.84
Current Liabilities₹2.44₹2.24
Net Current Asset₹3.94₹1.47
Non-Current Liabilities₹2.97₹2.45
Equity Capital₹15.84₹11.14
Total Equity & Liabilities₹21.25₹15.84

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024
Revenue₹16.27₹3.50
Other Income₹1.46₹1.34
Total Revenue₹17.73₹4.84
Total Expenses₹10.87₹2.41
Profit Before Tax₹6.86₹2.42
Tax₹1.48₹0.02
Profit After Tax₹5.38₹2.40
EPS - Basic₹6.39₹182.49
EPS - Diluted₹6.39₹182.49

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024
Profit before tax₹6.86₹2.42
Income before WC changes₹7.82₹5.05
Change in Assets-₹3.26-₹1.00
Change in Liabilities₹1.06₹1.04
Change in WC-₹2.20₹0.04
Cash flow from Operations₹4.13₹5.05
Cash flow from Investing-₹4.22-₹9.51
Cash flow from Financing₹0.00₹5.35
Total Cash Flow-₹0.08₹0.89
Cash (Start of the year)₹0.00₹0.00
Cash (End of the year)-₹0.08₹0.89

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024
Non-Current Assets₹12.40₹9.13
Current Assets₹5.10₹1.92
Total Assets₹17.50₹11.06
Current Liabilities₹2.12₹1.04
Net Current Asset₹2.98₹0.88
Non-Current Liabilities₹0.57₹0.59
Equity Capital₹14.81₹9.43
Total Equity & Liabilities₹17.50₹11.06
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
48.62
Neutral
ATR (14)
1.83
Neutral
STOCH(9,6)
59.82
Neutral
STOCH RSI (14)
68.31
Neutral
ADX(9)
26.87
Bearish
UO(9)
40.19
Neutral
ROC(12)
-2.19
Bearish
WillR(14)
-52.82
Neutral
Period
Simple value
Exponential vaue
5D
66.05
66.48
10D
67
66.83
20D
67.72
67.2
50D
68.48
68.91
100D
71.49
74.54

About INVICTA DIAGNOSTIC LTD

INVICTA DIAGNOSTIC LTD Share Price
ISIN
INE0XJ501010
Sector Market Cap

Invicta Diagnostic Limited is engaged in the diagnostic chain offering comprehensive radiology and pathology solutions. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology to customers under the brand name PC Diagnostics through its operational network, which consists of eight diagnostic centers and one centralized laboratory across Mumbai Metropolitan Region in the state of Maharashtra. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology which are performed at its own centers to cytogenetics and high-end molecular diagnostic tests which are outsourced to larger reference laboratories, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans and advanced positron emission tomography CT.

INVICTA DIAGNOSTIC LTD Financial Highlights

  • Revenue: INVICTA DIAGNOSTIC LTD reported revenue of ₹33.04 crore in FY26 vs ₹30.19 crore in FY25. It showed an increase of 9.44% on a yearly basis.
  • Operating Profit: INVICTA DIAGNOSTIC LTD reported an operating profit of ₹7.01 crore in FY26 vs ₹6.56 crore in FY25. It showed an increase of 6.86% on a year-on-year basis.
  • Net Profit: INVICTA DIAGNOSTIC LTD reported a net profit of ₹4.87 crore in FY26 vs ₹4.93 crore in FY25. It showed a decrease of 1.22% on a yearly basis.
Know more
Promoters
66.70%
FII
4.20%
Other DII
4.30%
Retail and other
24.81%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
INVICTA DIAGNOSTIC LTD Share Price
INVICTA DIAGNOSTIC LTD
Healthcare
Add Stock
Add Another

FAQs on INVICTA DIAGNOSTIC LTD Share Price